As of Nov 5, 2025, the Tenet Healthcare stock's price-to-earnings ratio is 14.08. This results from the current EPS of $14.82 and stock price of $208.62. The PE ratio has increased by 51% from the past four quarters average of 9.3.
The PE ratio of Tenet Healthcare has averaged 10.6 over the last seven years. The current price-to-earnings ratio of 14.08 is 33% more than the historical average. In the past seven years, THC's PE ratio reached its highest point in the Jun 2023 quarter at 16.99, when the stock price was $81.38 and the EPS was $4.79. The lowest point was recorded in the Dec 2024 quarter, when it reached 3.82 with a price of $126.23 and an EPS of $33.02.
Maximum annual increase: 1,344.14% in 2011
Maximum annual decrease: -79.55% in 2010
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 3.82 | -69.61% | $126.23 | $33.02 |
| 2023 | 12.57 | -1.1% | $75.57 | $6.01 |
| 2022 | 12.71 | 33.09% | $48.79 | $3.84 |
| 2021 | 9.55 | -9.13% | $81.69 | $8.55 |
| 2020 | 10.51 | N/A | $39.93 | $3.8 |
| 2019 | N/A | N/A | $38.03 | -$2.08 |
| 2018 | 16.8 | N/A | $17.14 | $1.02 |
| 2017 | N/A | N/A | $15.16 | -$7 |
| 2016 | N/A | N/A | $14.84 | -$1.93 |
| 2015 | N/A | N/A | $30.3 | -$1.41 |
| 2014 | 422.25 | N/A | $50.67 | $0.12 |
| 2013 | N/A | N/A | $42.12 | -$1.32 |
| 2012 | 24.05 | -42.57% | $32.47 | $1.35 |
| 2011 | 41.88 | 1,344.14% | $20.52 | $0.49 |
| 2010 | 2.9 | -79.55% | $26.76 | $9.24 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2025 | 13.7 | 23.42% | $203.04 | $14.82 |
| Jun 2025 | 11.1 | 26.71% | $176 | $15.86 |
| Mar 2025 | 8.76 | 129.32% | $134.5 | $15.36 |
| Dec 2024 | 3.82 | -27.38% | $126.23 | $33.02 |
| Sep 2024 | 5.26 | 9.36% | $166.2 | $31.6 |
| Jun 2024 | 4.81 | 19.95% | $133.03 | $27.66 |
| Mar 2024 | 4.01 | -68.1% | $105.11 | $26.21 |
| Dec 2023 | 12.57 | -12.83% | $75.57 | $6.01 |
| Sep 2023 | 14.42 | -15.13% | $65.89 | $4.57 |
| Jun 2023 | 16.99 | 12.37% | $81.38 | $4.79 |
| Mar 2023 | 15.12 | 18.96% | $59.42 | $3.93 |
| Dec 2022 | 12.71 | 27.61% | $48.79 | $3.84 |
| Sep 2022 | 9.96 | 54.66% | $51.58 | $5.18 |
| Jun 2022 | 6.44 | -33.2% | $52.56 | $8.16 |
| Mar 2022 | 9.64 | 0.94% | $85.96 | $8.92 |
Currently, THC's PE ratio is above its 3, 5 and 10-year historical averages.
With a P/E of 14.08, THC stands above its peers average but below the Healthcare sector and the industry average. Looking at its Healthcare sector average of 25.01, Tenet Healthcare's P/E is 44% lower.
THC's PE ratio is less than its peer stocks HCA and SEM, but it is above UHS's and DVA's. Tenet Healthcare's current PE ratio of 14.08 is more than the average of its peers, which is 11.73.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CYH Community Health Systems Inc | 1.53 | $521.53M |
| MD Mednax Inc | 11.21 | $1.86B |
| UHS Universal Health Services Inc | 11.69 | $14.36B |
| DVA Davita Inc | 12.21 | $8.48B |
| THC Tenet Healthcare Corp | 13.8 | $17.98B |
| SEM Select Medical Holdings Corp | 15.38 | $1.66B |
| HCA HCA Healthcare Inc | 17.95 | $107.22B |
THC stock has a price to earnings ratio of 14.08 as of Nov 5, 2025.
Over the last 3 years, the average PE ratio for THC stock is 10.27.
Over the last 5 years, the average PE ratio for THC stock is 10.29.
Over the last seven years, the quarterly PE ratio reached a historic high of 16.99 in the Jun 2023 quarter.
THC's price to earnings ratio is currently 33% above its 7-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Nov 5, 2025), Tenet Healthcare's stock price is $208.62. The earnings per share for the trailing twelve months (TTM) ending Sep 2025 is $14.82. Therefore, Tenet Healthcare's price to earnings ratio for today is 14.08. PE RATIO(14.08) = STOCK PRICE($208.62) / TTM EPS($14.82)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.